1-[(4-nitrophenyl)methyl]-1,2,4-triazole

We are 1-[(4-nitrophenyl)methyl]-1,2,4-triazole CAS:119192-09-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-[(4-nitrophenyl)methyl]-1,2,4-triazole
CAS.NO:119192-09-5
Synonyms:1-[(4-nitrophenyl)methyl]-1,2,4-triazole
1H-1,2,4-Triazole,1-[(4-nitrophenyl)methyl]
1-(1,2,4-triazol-1-ylmethyl)-4-nitrobenzene
1-p-Bitrobenzyl-1,2,4-triazole
1-(4-Nitrophenyl)methyl-1,2,4-triazole
1-(4-Nitrobenzyl)-1H-1,2,4-triazole
 
Physical and Chemical Properties:
Density 1.39g/cm3
Boiling Point 433.4ºC at 760mmHg
Molecular Formula C9H8N4O2
Molecular Weight 204.18500
Flash Point 215.9ºC
 
Specification:
Appearance:White to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rizatriptan benzoate(CAS:145202-66-0).

1-[(4-nitrophenyl)methyl]-1,2,4-triazole


Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.289042-10-0 Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.4-(Methylsulfonyl)phenylacetic acid According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.(R) – [N-3- (3-fluoro-4-morfolinilfenil) -2-oxo-5-oxazolidinil] metil azida CAS:168828-84-0 The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
5-fluoro-3-nitropyridin-2-amine View Details
Benzene-1,3-diamine dihydrochloride View Details
Piperidine-2,4-dione View Details
N,N-Diethylethylenediamine manufacturer Benzyl 2-Naphthyl Ether manufacturer 3-(2-methoxy-3-nitrophenyl)benzoic acid manufacturer 2,3-Di-O-para-toluoyl-D-tartaric acid manufacturer decyl prop-2-enoate manufacturer